956 Retifanlimab (INCMGA00012) in patients with recurrent MSI-H or dMMR endometrial cancer: results from the POD1UM-101 study
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2021-11-01
|
| 叢編: | Journal for ImmunoTherapy of Cancer |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|